Proteome Analysis of Differential Protein Expression in Brain of Rats with Type 1 Diabetes Mellitus

被引:23
作者
Li, X.
Pan, W. [1 ]
Yang, G. Z.
Di, Y. N.
Zhao, F.
Zhu, L. Y.
Jiang, Z. H.
机构
[1] Guiyang Med Coll, Dept Lab Med, Guiyang 550004, Guizhou, Peoples R China
关键词
proteome; type 1 diabetes mellitus; brain; streptozotocin; GEL-ELECTROPHORESIS; HIPPOCAMPUS; PREVALENCE;
D O I
10.1055/s-0031-1271705
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Aim of the study: Proteomic approach was applied to identify differential protein expressed in brain of rats with type 1 diabetes mellitus (T1DM) in order to search for potential biomarkers for pathological changes of brain with T1DM. Methods: Proteins were extracted from brain tissues of T1DM rats and healthy control rats, separated by 2-DE and identified by MALDI-TOF-MS. The results were validated by Western blot analysis and immunohistochemistry (IHC). Results: A total of 8 proteins from the 24 differentially expressed spots were identified by MALDI-TOF-MS. The proteins identified were vitamin D-dependent calcium-binding protein, creatine kinase B-type (B-CK), myosin light chain kinase (MLCK), HSP60 and HSP71, ATP synthase, cyclin-G, pantothenate kinase-1 (PANK1), respectively. 3 proteins were up-regulated and 5 proteins were down-regulated from the T1DM rats. Of the 8 proteins identified, MLCK was confirmed by Western blot and IHC. Conclusion: This work demonstrates that a comprehensive strategy of proteomic identification should be a useful tool for understanding of diabetic encephalopathy mechanism. And the differential proteins such as MLCK may be give clues about the pathogenesis of diabetic encephalopathy.
引用
收藏
页码:265 / 270
页数:6
相关论文
共 27 条
[1]
Increased Expression of Phosphorylated Smad2 and Smad3 in the Hippocampus of Streptozotocin-induced Diabetic Rats [J].
Bao, Y. ;
Jiang, L. ;
Shi, Y. -Q. ;
Zou, J. -J. ;
Zhao, Y. ;
Liu, Z. -M. .
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2010, 118 (01) :47-50
[2]
Cerebral dysfunction in type 1 diabetes: effects of insulin, vascular risk factors and blood-glucose levels [J].
Brands, AMA ;
Kessels, RPC ;
de Haan, EHF ;
Kappelle, LJ ;
Biessels, GJ .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 490 (1-3) :159-168
[3]
Neuroprotection in Diabetic Encephalopathy [J].
Fazeli, Seyyed Amirhossein .
NEURODEGENERATIVE DISEASES, 2009, 6 (5-6) :213-218
[4]
Application of proteomics technologies in the investigation of the brain [J].
Fountoulakis, M .
MASS SPECTROMETRY REVIEWS, 2004, 23 (04) :231-258
[5]
Proteomics-driven progress in neurodegeneration research [J].
Fountoulakis, Michael ;
Kossida, Sophia .
ELECTROPHORESIS, 2006, 27 (08) :1556-1573
[6]
Changes in expression of adrenomedullin in the myocardium of streptozotocin-induced diabetic rats [J].
He Rong-xin ;
Gu Chuan-long ;
Shen Fang ;
Zhang Xiao-ming .
CHINESE MEDICAL JOURNAL, 2007, 120 (03) :187-191
[7]
Streptozotocin-induced diabetes progressively increases blood-brain barrier permeability in specific brain regions in rats [J].
Huber, Jason D. ;
VanGilder, Reyna L. ;
Houser, Kimberly A. .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2006, 291 (06) :H2660-H2668
[8]
Jian X, 1996, J NEUROBIOL, V31, P567
[9]
C-peptide and central nervous system complications in diabetes [J].
Li, ZG ;
Sima, AAF .
EXPERIMENTAL DIABESITY RESEARCH, 2004, 5 (01) :79-90
[10]
Liang Xiao-chun, 2006, Chin J Integr Med, V12, P68